CliffBio
small molecule

ALEVE PM

DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare Consumer Care →See this company's full patent-cliff portfolio

Drug detail

Brand nameALEVE PM
Active ingredientDIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Strength25MG;220MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2014
Marketing statusOTC

More from Bayer Healthcare Consumer Care

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALEVE PM patent cliff — loss of exclusivity — | CliffBio